High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER breast cancer.

CDK4/6 inhibitors combined with endocrine therapy have demonstrated higher antitumor activity than endocrine therapy alone for the treatment of advanced estrogen receptor-positive breast cancer. Some of these tumors are de novo resistant to CDK4/6 inhibitors and others develop acquired resistance. Here, we show that p16 overexpression is associated with reduced antitumor activity of CDK4/6 inhibitors in patient-derived xenografts (n = 37) and estrogen receptor-positive breast cancer cell lines, as well as reduced response of early and advanced breast cancer patients to CDK4/6 inhibitors (n = 89).

Kinetic resolution of (R,S)-2-butanol using enzymatic synthesis of esters.

Kinetic resolution of (R,S)-2-butanol using enzymatic synthesis of esters has been studied. (R,S)-2-Butanol is commonly found as a racemic mixture, and the products of its esterification are racemic mixtures too. This work is of great significance in the field of the enzymatic kinetic resolution due to the little information found in literature about the resolution of (R,S)-2-butanol as pure compound.

Adsorption and diffusion parameters of methane and nitrogen on microwave-synthesized ETS-4.

ETS-4 is a titanium silicate developed by Engelhard Corporation, which possesses a small pore network, the size of which can be reduced by heat treatment to improve its kinetic selectivity in nitrogen/methane separation. Most of the reported studies about ETS-4 employ crystals synthesized with conventional heating. Furthermore, information available on the adsorption properties of ETS-4, especially the diffusion properties, is scarce.